Stock VITAE PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Vitae Pharmaceuticals Inc

Equities

US92847N1037

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Vitae Pharmaceuticals Inc
2015 Assured Guaranty : Wall St. tumbles as investors flee equities on Greek debt crisis RE

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Vitae Pharmaceuticals : Allergan and Vitae Pharmaceuticals Announce Expiration of HSR Waiting Period for Allergan's Proposed Acquisition of Vitae
PR
Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information
BU
Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information
BU
Vitae Pharmaceuticals : Allergan to Acquire Vitae Pharmaceuticals Adding Innovative Development Programs for Dermatologic Conditions
PR
Vitae Pharmaceuticals to Present at Wells Fargo Healthcare Conference
GL
Vitae Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference
GL
Vitae Pharmaceuticals Appoints Scott Applebaum as General Counsel and Corporate Secretary
GL
Vitae Pharmaceuticals Reports Second Quarter 2016 Operating and Financial Results
GL
Vitae Pharmaceuticals to Announce Second Quarter 2016 Financial Results on August 3, 2016
GL
Vitae Pharmaceuticals Appoints Daniel M. Junius to Board of Directors
GL
Vitae Pharmaceuticals to Present at JMP Securities Life Sciences Conference
GL
Vitae Pharmaceuticals : Announces Appointment of Carole Sable, M.D., as Chief Medical Officer
PU
Vitae Pharmaceuticals Announces Appointment of Carole Sable, M.D., as Chief Medical Officer
GL
Vitae Pharmaceuticals Reports First Quarter 2016 Operating and Financial Results
GL
Vitae Pharmaceuticals to Present at IMMUNOLOGY 2016
GL
Vitae Pharmaceuticals to Announce First Quarter 2016 Financial Results on May 10, 2016
GL
Vitae Pharmaceuticals Closes Public Offering of Common Stock
GL
Vitae Pharmaceuticals Prices Public Offering of Common Stock
GL
Vitae Pharmaceuticals Proposes Public Offering of Common Stock
GL
Vitae Pharmaceuticals Achieves Proof-of-Concept with First-in-Class RORyt Inhibitor in Moderate to Severe Psoriasis
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Vitae Pharmaceuticals Inc